Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurosurgery

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/01.NEU.0000325687.45344.9EPMID 18981857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL

  2007cited by this paper
• The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis

  2006cited by this paper
• CXCR4 expression mediates glioma cell invasiveness

  2006cited by this paper
• Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

  2006cited by this paper
• Chemokine Receptor CXCR4 Expression in Patients With Melanoma and Colorectal Cancer Liver Metastases and the Association With Disease Outcome

  2006cited by this paper
• Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma

  2005cited by this paper
• Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

  2005cited by this paper
• Adverse drug reactions: A broader perspective

  2004cited by this paper
• The significance of cancer cell expression of the chemokine receptor CXCR4.

  2004cited by this paper
• A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

  2003cited by this paper
• Stromal Cell-derived Factor 1α Stimulates Human Glioblastoma Cell Growth through the Activation of Both Extracellular Signal-regulated Kinases 1/2 and Akt

  2003cited by this paper
• Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

  2000cited by this paper

• Interstitial fluid transport dynamics predict glioblastoma invasion and progression

  2025cites this paper
• CXCL12 impact on glioblastoma cells behaviors under dynamic culture conditions: Insights for developing new therapeutic approaches

  2024cites this paper
• PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach

  2023cites this paper
• Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle

  2022cites this paper
• Targeting CXCR4 to suppress glioma‐initiating cells and chemoresistance in glioma

  2022cites this paper
• Non-coding RNAs and glioma: Focus on cancer stem cells

  2022cites this paper
• Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

  2022cites this paper
• C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using 64Cu-Radiolabeled Ultrasmall Gold Nanoclusters.

  2021cites this paper
• A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy

  2021cites this paper
• CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats

  2021cites this paper
• Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.

  2017cites this paper
• CXCR 4 and Cancer

  2017cites this paper
• Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.

  2014cites this paper
• The role of the CXCR4 cell surface chemokine receptor in glioma biology

  2013cites this paper
• Contribution of SDF-1α/CXCR4 Signaling to Brain Development and Glioma Progression

  2012cites this paper
• Molecular and Cellular Pathobiology CXCR 4 Activation De fi nes a New Subgroup of Sonic Hedgehog – Driven Medulloblastoma

  2011cites this paper
• Chemokines and Cancer Metastasis

  2011cites this paper
• The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network

  2011cites this paper
• CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.

  2010cites this paper
• A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion

  2010cites this paper
• Targeting Energy Metabolism in Brain Cancer

  2010cites this paper
• Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

  2010cites this paper
• CXCR4 and cancer

  2010cites this paper
• Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma.

  2009cites this paper
• T2 detection of tumor invasion within segmented components of glioblastoma multiforme

  2009cites this paper